• (-)-Norepinephrine (+)-bitartrate in Shock Research

  2026-08-20

  (-)-Norepinephrine (+)-bitartrate offers a receptor-informed way to study vascular tone, cardiac stress, and adrenergic receptor signaling. This article explains how the VNERi framework can improve experimental interpretation without confusing vasomotor tone with vascular responsiveness.

• Pexidartinib (PLX3397): CSF1R Research Guide

  2026-08-20

  Pexidartinib, also called PLX3397, is an orally bioavailable ATP-competitive small-molecule inhibitor used to study CSF1R-dependent macrophage biology. Its reported cellular potency and formulation limits support controlled cancer research workflows, but they do not establish direct SPP1 inhibition or clinical efficacy.

• KR-12 Human Antimicrobial Peptide: Evidence

  2026-08-19

  KR-12 is a compact human antimicrobial peptide derived from LL-37 that targets bacterial anionic membranes. Its reported narrow-spectrum activity, anti-biofilm effects, copper binding, and mammalian-cell tolerance make it a useful research reagent, while assay conditions and translational limits require careful interpretation.

• CUDC-907: Practical Dual PI3K/HDAC Workflow

  2026-08-19

  CUDC-907 is a dual PI3K and HDAC inhibitor for controlled cell-based studies that require coordinated interrogation of PI3K/AKT signaling and histone deacetylase activity. This guide covers formulation, treatment setup, QC, and interpretation boundaries; the compound is for scientific research only and not for diagnostic, therapeutic, or clinical use.

• Cy7 NHS Ester (A8109): Practical NIR Labeling

  2026-08-18

  Cy7 NHS ester (SKU A8109) is a water-soluble protein labeling dye for attaching near-infrared fluorescence to accessible amino groups in proteins, peptides, and related biomolecules. It is suited to controlled in vitro conjugation and near-infrared fluorescent imaging workflows, but labeling efficiency, cell compatibility, biodistribution, and in vivo performance must be validated for each target.

• InstaBlue Protein Stain Solution Protocol

  2026-08-18

  InstaBlue Protein Stain Solution provides rapid Coomassie Brilliant Blue visualization of protein bands in polyacrylamide gels without fixation, washing, or destaining. It is intended for protein electrophoresis analysis and workflow screening, but detection limits, quantitative linearity, and downstream mass spectrometry performance should be validated for each gel system and sample type.

• Recombinant Mouse M-CSF in Macrophage Assays

  2026-08-17

  Recombinant Mouse Macrophage Colony Stimulating Factor supports controlled studies of macrophage survival, differentiation, metabolism, and inflammatory signaling. This guide explains how to use M-CSF as an experimental baseline when dissecting the IGF2BP1–THBS1–TLR4 fibrosis axis and designing more interpretable assays.

• Prednisone: A Matrix-Aware Research Framework

  2026-08-17

  Prednisone is a synthetic corticosteroid whose lymphocyte effects are best interpreted through coordinated cell-cycle, cytokine, and apoptosis measurements. This article translates metabolomics lessons from botanical digestion research into a practical framework for designing more rigorous Prednisone assays.

• FPR2/ALX in Autoimmune Astrocytopathy

  2026-08-16

  The reference study shows that pharmacological FPR2/ALX stimulation with Quin-C1 limits AQP4-IgG- and complement-mediated autoimmune astrocytopathy in mice. Depletion and pathway-inhibition experiments associate this protection with microglial and natural killer cell activity and with SYK-AKT signaling, providing a mechanistic framework for further neuroinflammation research.

• Perphenazine: Dopamine D2 Antagonist Workflows

  2026-08-15

  Perphenazine supports practical studies spanning dopamine signaling, mitochondrial injury, opioid tolerance suppression, and host-directed antibacterial research. This guide connects mechanism-driven assay design with formulation, controls, and troubleshooting strategies for more interpretable results.

• Prednisolone, ERAD, and Translational Signal Design

  2026-08-15

  Prednisolone is more than a routine corticosteroid control: it can help translational researchers define how glucocorticoid receptor-driven state changes influence inflammation, immunity, and membrane-protein biology. When interpreted alongside the 2026 development of ERAD-engaging chimeras, it also clarifies a crucial experimental distinction between changing cellular signaling and selectively eliminating a target protein. This article presents a practical framework for combining both perspectives without conflating Prednisolone pharmacology with ERAD-mediated degradation.

• L-Glutathione Reduced: Redox Workflow Guide

  2026-08-14

  L-Glutathione Reduced supports controlled redox perturbation, oxidative-stress rescue experiments, and GST affinity elution without introducing an ethanol or DMSO vehicle. This practical guide connects reduced glutathione handling to GOT1-focused pancreatic cancer assays, metabolic profiling, and reproducible troubleshooting.

• Irinotecan Assays: From Prodrug to Readout

  2026-08-14

  Irinotecan and CPT-11 assays are most informative when prodrug activation, DNA damage, apoptosis, and exposure timing are analyzed together. This evidence-centered guide translates product data and a key pharmacology review into practical colorectal cancer research decisions.

• AZD0156 Workflow for ATM Kinase Inhibition

  2026-08-13

  Build a selective ATM kinase inhibition workflow around AZD0156, from solvent handling and cellular target engagement to DNA damage combination studies. The approach combines orthogonal pharmacology with phosphoproteomic and metabolic follow-up assays to distinguish genuine pathway modulation from nonspecific cytotoxicity.

• Phenothiazines, ROS, and Autophagy in Macrophages

  2026-08-13

  The reference study identifies phenothiazines as host-directed therapy candidates that strengthen macrophage defense against intracellular bacteria through coordinated reactive oxygen species production, lysosomal activation, and autophagy. Pharmacological inhibition of autophagy or ROS reduced the antibacterial effect, while perphenazine improved infection-associated tissue outcomes in a Salmonella Typhimurium model, providing a mechanistic basis for further investigation.

448 records 7/30 page Previous Next First page 上5页 678910 下5页 Last page